ES545482A0 - Un procedimiento para preparar compuestos de amidina - Google Patents

Un procedimiento para preparar compuestos de amidina

Info

Publication number
ES545482A0
ES545482A0 ES545482A ES545482A ES545482A0 ES 545482 A0 ES545482 A0 ES 545482A0 ES 545482 A ES545482 A ES 545482A ES 545482 A ES545482 A ES 545482A ES 545482 A0 ES545482 A0 ES 545482A0
Authority
ES
Spain
Prior art keywords
procedure
amidine compounds
preparing amidine
preparing
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES545482A
Other languages
English (en)
Other versions
ES8607218A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Torii and Co Ltd
Original Assignee
Torii and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torii and Co Ltd filed Critical Torii and Co Ltd
Publication of ES545482A0 publication Critical patent/ES545482A0/es
Publication of ES8607218A1 publication Critical patent/ES8607218A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES545482A 1984-07-25 1985-07-23 Un procedimiento para preparar compuestos de amidina Expired ES8607218A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15504584A JPS6133173A (ja) 1984-07-25 1984-07-25 アミジン化合物

Publications (2)

Publication Number Publication Date
ES545482A0 true ES545482A0 (es) 1986-05-16
ES8607218A1 ES8607218A1 (es) 1986-05-16

Family

ID=15597463

Family Applications (1)

Application Number Title Priority Date Filing Date
ES545482A Expired ES8607218A1 (es) 1984-07-25 1985-07-23 Un procedimiento para preparar compuestos de amidina

Country Status (19)

Country Link
US (2) US4777182A (es)
EP (1) EP0190356B1 (es)
JP (1) JPS6133173A (es)
KR (2) KR870001087B1 (es)
AU (1) AU567039B2 (es)
CA (1) CA1254205A (es)
CS (1) CS255891B2 (es)
DD (1) DD235637A5 (es)
DE (1) DE3582057D1 (es)
DK (1) DK169069B1 (es)
ES (1) ES8607218A1 (es)
FI (1) FI78461C (es)
HU (1) HU195769B (es)
MX (1) MX160912A (es)
NO (1) NO163954C (es)
PH (1) PH20585A (es)
SU (1) SU1456008A3 (es)
WO (1) WO1986000893A1 (es)
ZA (1) ZA855552B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3824236C1 (es) * 1988-07-16 1989-12-28 Heidelberger Druckmaschinen Ag, 6900 Heidelberg, De
CA2032420A1 (en) * 1989-12-22 1991-06-23 Akira Okuyama Guanidinobenzene derivatives
US5238964A (en) * 1990-04-05 1993-08-24 Torii & Co., Ltd. Agent for treatment of cerebrovascular contraction
US5652237A (en) * 1994-09-09 1997-07-29 Warner-Lambert Company 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes
RU2142799C1 (ru) * 1995-01-05 1999-12-20 Тории Фармасьютикал Ко., Лтд Тромболитические средства
ATE222583T1 (de) * 1995-01-05 2002-09-15 Torii Pharmaceutical Co Ltd Derivate substituierter amidinonaphthylester
AU736951C (en) 1998-03-19 2003-02-20 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
WO2001077082A1 (fr) * 1999-06-02 2001-10-18 Torii Pharmaceutical Co., Ltd. Derives de naphtalene
AU2000252458A1 (en) * 2000-06-08 2001-12-17 Shizuoka Coffein Co., Ltd. Benzene derivatives
EP1884236B1 (en) * 2005-05-17 2011-03-02 Santen Pharmaceutical Co., Ltd. Angiogenesis inhibitor containing amine derivative as active ingredient
ES2354223T3 (es) * 2005-05-17 2011-03-11 Santen Pharmaceutical Co., Ltd. Derivados de amidina para uso en la prevención o el tratamiento de glaucoma.
WO2008058167A2 (en) * 2006-11-07 2008-05-15 Case Western Reserve University Method for treating disorders associated with complement activation
JP6042330B2 (ja) 2010-07-09 2016-12-14 ビーエイチヴィ ファーマ、インコーポレイテッド レモグリフロジンを含めた半減期が短い医薬品のための組合せ即時/遅延放出送達システム
JP6252991B2 (ja) * 2012-07-04 2017-12-27 味の素株式会社 ナファモスタットメシル酸塩の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292429A (en) * 1978-03-08 1981-09-29 Ciba-Geigy Corporation Imidazole urea and amido compounds
JPS57179146A (en) * 1981-04-28 1982-11-04 Torii Yakuhin Kk Amidine compound
AU527371B2 (en) * 1980-09-16 1983-03-03 Torii & Co., Ltd. Amidine
JPS60130561A (ja) * 1983-12-16 1985-07-12 Torii Yakuhin Kk アミジン誘導体およびそれを含む強心剤

Also Published As

Publication number Publication date
HUT42433A (en) 1987-07-28
US4820730A (en) 1989-04-11
DE3582057D1 (en) 1991-04-11
JPS6133173A (ja) 1986-02-17
WO1986000893A1 (en) 1986-02-13
ZA855552B (en) 1986-03-26
DD235637A5 (de) 1986-05-14
NO163954B (no) 1990-05-07
HU195769B (en) 1988-07-28
EP0190356A4 (en) 1987-12-09
FI78461B (fi) 1989-04-28
CS255891B2 (en) 1988-03-15
AU4549285A (en) 1986-02-25
PH20585A (en) 1987-02-20
AU567039B2 (en) 1987-11-05
US4777182A (en) 1988-10-11
DK96286D0 (da) 1986-03-03
FI78461C (fi) 1989-08-10
DK96286A (da) 1986-03-03
JPH0461868B2 (es) 1992-10-02
FI860904A0 (fi) 1986-03-04
KR870001087B1 (ko) 1987-06-04
NO163954C (no) 1990-08-15
ES8607218A1 (es) 1986-05-16
CS546385A2 (en) 1987-07-16
EP0190356B1 (en) 1991-03-06
MX160912A (es) 1990-06-14
NO860865L (no) 1986-04-10
CA1254205A (en) 1989-05-16
DK169069B1 (da) 1994-08-08
SU1456008A3 (ru) 1989-01-30
EP0190356A1 (en) 1986-08-13
FI860904A (fi) 1986-03-04
KR860700250A (ko) 1986-08-01

Similar Documents

Publication Publication Date Title
ES548135A0 (es) Un procedimiento para preparar dioxafosforinanos
ES547903A0 (es) Un procedimiento para preparar derivados de fluoro-fenoxife-nilo
ES551517A0 (es) Un procedimiento para preparar aril-hidroxamatos
ES550503A0 (es) Un procedimiento para preparar compuestos de carbapenem
ES545347A0 (es) Un procedimiento para preparar derivados de pirimidina
MX164160B (es) Un procedimiento para preparar un compuesto neoalcoxi
ES545386A0 (es) Un procedimiento para preparar un organotitanato
ES552089A0 (es) Un procedimiento para preparar compuestos de oxazolidina-fenol-alcohol
ES545482A0 (es) Un procedimiento para preparar compuestos de amidina
ES543929A0 (es) Un procedimiento para preparar un p-isononanoiloxibenceno- sulfonato
ES549860A0 (es) Un procedimiento para preparar aminoacil-ladanos
ES548409A0 (es) Un procedimiento para preparar derivados de bencimidazol
ES546157A0 (es) Un procedimiento para preparar quinolonas
ES544863A0 (es) Un procedimiento para preparar un compuesto de beta-lactama
ES542149A0 (es) Un procedimiento para preparar hidroxi-4-2h-1-benzotiopiran-2-onas
ES547419A0 (es) Un procedimiento para preparar derivados de pirimidina
ES544864A0 (es) Un procedimiento para preparar 4-acetoxi-3-hidroxietilazeti-zin-2-ona
ES550443A0 (es) Un procedimiento para preparar un compuesto de fosforo orga-nico
ES540784A0 (es) Un procedimiento para preparar compuestos relacionados con espergualina
ES552911A0 (es) Un procedimiento para preparar derivados de 3-carbonil-1-aminoalquil-1h-indol
ES544862A0 (es) Un metodo para preparar un compuesto de morfolinol
ES546690A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indoldiona
ES547458A0 (es) Un procedimiento para preparar derivados de piridiloxi
ES544625A0 (es) Un procedimiento para preparar derivados de penem
ES544381A0 (es) Un procedimiento para preparar 5-desoxi-l-arabinosa